Legend Biotech reported earnings of $ 0.14 per LEGN share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | $ 0.01 |
| Earnings Per Share (Surprise) | $ 0.14 (+$ 0.13) |
| Last Year's EPS | -$ 0.15 |
| EPS YoY Change |
Out of the last 32 earnings reporting periods, Legend Biotech beat analysts’ expectations 16 times and fell short of expectations 9 time(s). Legend Biotech reported earnings per share of $ 0.14 in the last report surpassing an estimated EPS of $ 0.01 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | $ 0.01 | $ 0.14 | -$ 0.11 | |
| Aug 11, 2026 | $ 0.12 | $ 0.09 | -$ 0.34 | |
| May 12, 2026 | -$ 0.02 | -$ 0.15 | -$ 0.07 | |
| Mar 10, 2026 | -$ 0.17 | -$ 0.08 | -$ 0.15 | |
| Nov 12, 2025 | -$ 0.13 | -$ 0.11 | -$ 0.34 | |
| Aug 11, 2025 | -$ 0.11 | -$ 0.34 | -$ 0.05 | |
| May 13, 2025 | -$ 0.23 | -$ 0.07 | -$ 0.16 | |
| Mar 11, 2025 | -$ 0.25 | -$ 0.15 | -$ 0.40 | |
| Nov 12, 2024 | -$ 0.35 | -$ 0.34 | -$ 0.17 | |
| Aug 9, 2024 | -$ 0.54 | -$ 0.05 | -$ 1.14 | |
| May 13, 2024 | -$ 0.29 | -$ 0.16 | -$ 0.40 | |
| Mar 11, 2024 | -$ 0.70 | -$ 0.40 | -$ 0.85 | |
| Nov 20, 2023 | -$ 0.56 | -$ 0.17 | -$ 0.41 | |
| Aug 15, 2023 | -$ 0.69 | -$ 1.14 | -$ 0.54 | |
| May 18, 2023 | -$ 0.56 | -$ 0.40 | -$ 0.26 | |
| Mar 30, 2023 | -$ 0.44 | -$ 0.85 | -$ 0.30 | |
| Feb 17, 2023 | -$ 0.44 | -$ 0.41 | -$ 0.60 | |
| Sep 30, 2022 | - | -$ 0.54 | -$ 0.43 | |
| Jun 1, 2022 | -$ 0.46 | -$ 0.26 | -$ 0.32 | |
| Mar 18, 2022 | -$ 0.35 | -$ 0.30 | -$ 0.30 |
Legend Biotech’s stock was trading at $ 24.29 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, LEGN’s price decreased to $ 19.54 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | $ 0.14 | $ 24.29 | $ 19.54 | |
| Aug 11, 2026 | $ 0.09 | $ 20.66 | $ 20.65 | |
| May 12, 2026 | -$ 0.15 | $ 25.58 | $ 28.67 | |
| Mar 10, 2026 | -$ 0.08 | $ 19.14 | $ 20.27 | |
| Nov 12, 2025 | -$ 0.11 | $ 32.03 | $ 31.01 | |
| Aug 11, 2025 | -$ 0.34 | $ 37.00 | $ 36.99 | |
| May 13, 2025 | -$ 0.07 | $ 32.38 | $ 27.80 | |
| Mar 11, 2025 | -$ 0.15 | $ 34.03 | $ 38.24 | |
| Nov 12, 2024 | -$ 0.34 | $ 40.04 | $ 39.35 | |
| Aug 9, 2024 | -$ 0.05 | $ 56.91 | $ 56.25 | |
| May 13, 2024 | -$ 0.16 | $ 43.24 | $ 44.38 | |
| Mar 11, 2024 | -$ 0.40 | $ 63.25 | $ 65.13 | |
| Nov 20, 2023 | -$ 0.17 | $ 64.56 | $ 57.25 | |
| Aug 15, 2023 | -$ 1.14 | $ 70.35 | $ 67.65 | |
| May 18, 2023 | -$ 0.40 | $ 71.35 | $ 69.73 | |
| Mar 30, 2023 | -$ 0.85 | $ 48.14 | $ 48.22 | |
| Feb 17, 2023 | -$ 0.41 | $ 49.04 | $ 47.89 | |
| Sep 30, 2022 | -$ 0.54 | $ 40.11 | $ 40.28 | |
| Jun 1, 2022 | -$ 0.26 | $ 42.29 | $ 43.25 | |
| Mar 18, 2022 | -$ 0.30 | $ 39.00 | $ 38.23 |
Legend Biotech released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Legend Biotech beat analysts’ expectations during the last earnings period by
